Nissay Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.34M Buy
24,367
+831
+4% +$45.7K 0.01% 579
2025
Q1
$1.66M Buy
23,536
+283
+1% +$20K 0.01% 550
2024
Q4
$1.56M Buy
23,253
+334
+1% +$22.3K 0.01% 576
2024
Q3
$1.61M Buy
22,919
+699
+3% +$49.1K 0.01% 576
2024
Q2
$1.83M Buy
22,220
+849
+4% +$69.9K 0.01% 523
2024
Q1
$1.87M Buy
21,371
+428
+2% +$37.4K 0.01% 524
2023
Q4
$2.02M Buy
20,943
+729
+4% +$70.3K 0.02% 461
2023
Q3
$1.79M Buy
20,214
+710
+4% +$62.8K 0.02% 468
2023
Q2
$1.69M Sell
19,504
-308
-2% -$26.7K 0.01% 487
2023
Q1
$1.93M Sell
19,812
-722
-4% -$70.2K 0.02% 442
2022
Q4
$2.13M Sell
20,534
-46
-0.2% -$4.76K 0.02% 420
2022
Q3
$1.75M Buy
20,580
+911
+5% +$77.2K 0.02% 448
2022
Q2
$1.63M Sell
19,669
-55
-0.3% -$4.56K 0.02% 463
2022
Q1
$1.52M Buy
19,724
+476
+2% +$36.7K 0.01% 535
2021
Q4
$1.7M Buy
19,248
+582
+3% +$51.4K 0.01% 522
2021
Q3
$1.44M Buy
18,666
+840
+5% +$64.9K 0.01% 533
2021
Q2
$1.49M Buy
17,826
+334
+2% +$27.9K 0.01% 533
2021
Q1
$1.32M Sell
17,492
-56,945
-77% -$4.3M 0.01% 545
2020
Q4
$6.53M Sell
74,437
-12,855
-15% -$1.13M 0.1% 169
2020
Q3
$6.64M Buy
87,292
+11,381
+15% +$866K 0.11% 150
2020
Q2
$9.36M Buy
75,911
+17,557
+30% +$2.17M 0.18% 117
2020
Q1
$4.93M Buy
58,354
+43,537
+294% +$3.68M 0.13% 172
2019
Q4
$1.25M Buy
14,817
+447
+3% +$37.8K 0.03% 460
2019
Q3
$969K Buy
14,370
+748
+5% +$50.4K 0.02% 506
2019
Q2
$1.17M Sell
13,622
-336
-2% -$28.8K 0.03% 450
2019
Q1
$1.24M Buy
13,958
+827
+6% +$73.5K 0.03% 438
2018
Q4
$1.12M Buy
13,131
+589
+5% +$50.1K 0.03% 409
2018
Q3
$1.22M Buy
12,542
+464
+4% +$45K 0.03% 418
2018
Q2
$1.14M Buy
12,078
+556
+5% +$52.4K 0.03% 416
2018
Q1
$934K Buy
11,522
+171
+2% +$13.9K 0.03% 450
2017
Q4
$1.01M Buy
+11,351
New +$1.01M 0.03% 421